Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2012 015 536.1 |
96 | EP file number | EAKZ | 12 82 6589.9 |
86 | WO file number | WAKZ | PCT/US2012/071306 |
97 | EP publication number | EPN | 2794610 |
87 | WO publication number | WPN | 2013096800 |
54 | Designation/title | TI | VERFAHREN UND ZWISCHENPRODUKTE ZUR HERSTELLUNG VON PRALATREXAT |
51 | IPC main class | ICM (ICMV) | C07D 475/08 (2006.01) |
22 | DE application date | DAT | Dec 21, 2012 |
96 | EP application date | EAT | Dec 21, 2012 |
86 | WO application date | WAT | Dec 21, 2012 |
43 | Date of first publication | OT | Jun 27, 2013 |
| Date of publication of grant | PET | Mar 9, 2016 |
71/73 | Applicant/owner | INH | Biljan, Tomislav, Krizevci, HR; Canavesi, Augusto, Locate Varesino, IT; Galluzzo, Christian, Novara, IT; Teva Pharmaceuticals International GmbH, Jona, CH; Tiseni, Paolo, Simone, Bresso, IT |
72 | Inventor | IN | TISENI, Paolo, Simone, 28100 Novara, IT; GALLUZZO, Christian, CAP 28100 Novara, IT; CANAVESI, Augusto, 22070 Locate Varesino, IT; BILJAN, Tomislav, 48260 Krizevci, HR |
74 | Representative | VTR | D Young & Co LLP, 80331 München, DE |
| Address for service | | D Young & Co LLP, London EC2V 7BQ, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261656161 P Jun 6, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201161578491 P Dec 21, 2011
|
| Due date | FT FG | Dec 31, 2025 Annual fee for the 14th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002794610 Searchable text:
EP000002794610 Original document:
EP000002794610B1 Searchable text:
EP000002794610B1 Original document:
WO002013096800 Searchable text:
WO002013096800 |
43 | Date of first publication | EVT | Jun 27, 2013 |
| Date of the first transfer into DPMAregister | EREGT | Dec 12, 2014 |
| Date of the (most recent) update in DPMAregister | REGT | Nov 30, 2024 (Show all update days)(Hide all update days)- Nov 30, 2024
- Due date: changed
- Procedures: Procedure relating to PCT application, Publication of PCT application, 27.06.2013: deleted
- Mar 19, 2024; Nov 29, 2023; Dec 17, 2022; Dec 18, 2021; Dec 22, 2020; Oct 20, 2020; Dec 18, 2019; Aug 13, 2019; Mar 28, 2019; Dec 19, 2018; Jan 3, 2018; Sep 14, 2017; May 11, 2017; Mar 23, 2017; Feb 16, 2017; Dec 21, 2016; Aug 4, 2016; Jun 25, 2016; Apr 30, 2016; Apr 13, 2016; Mar 17, 2016; Mar 10, 2016
- Historical data not available for this/these date(s)
- Dec 12, 2014
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 24, 2016 |
| Issue number | HN | 31 |
| Year | PJ | 2016 |
| Publication date | VT | Aug 4, 2016 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Biljan, Tomislav, Krizevci, HR; Canavesi, Augusto, Locate Varesino, IT; Galluzzo, Christian, Novara, IT; Teva Pharmaceuticals International GmbH, Jona, CH; Tiseni, Paolo, Simone, Bresso, IT |
71/73 | Previous applicant/owner | INHF | Biljan, Tomislav, Krizevci, HR, Canavesi, Augusto, Locate Varesino, IT, Galluzzo, Christian, Novara, IT, Plus Chemicals SA, Paradiso, CH, Tiseni, Paolo, Simone, Novara, US |